[Hepatitis C antibodies in groups at epidemic risk].
Blood sera from patients with acute virus hepatitis, sexually transmitted diseases, psychiatric and oncological diseases and pulmonary tuberculosis were studied for the presence of antibodies to hepatitis C virus (anti-HCV) and HBsAg with the use of solid-phase enzyme immunoassay. Anti-HCV were detected, respectively, in 9.1% and 67.8% of patients with acute virus hepatitis, in 5.7% and 6.1% of patients with sexually transmitted diseases, in 7.5% and 9.2% of psychiatric patients, in 7.5% and 13% with pulmonary tuberculosis and malignant tumors.
Sailov
M D
MD
National Center of Oncology, Medical University, Baku, Azerbaijan.
Mamedov
M K
MK
Gaibov
N T
NT
D000208:Acute Disease; D001382:Azerbaijan / Q000453:epidemiology; D004196:Disease Outbreaks; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006526:Hepatitis C / Q000453:epidemiology* / Q000276:immunology*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D008297:Male; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D014505:Urban Population / Q000706:statistics & numerical data
D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies
Antitela k virusu gepatita C v nekotorykh gruppakh épidemicheskogo riska.